<DOC>
	<DOCNO>NCT00360750</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , carboplatin , vincristine , etoposide , cytarabine , work different way stop growth tumor cell , either kill cell stop divide . Radiation therapy use high-energy x-ray kill tumor cell . Giving chemotherapy without radiation therapy surgery may kill tumor cell remain surgery . Sometimes , surgery , tumor need treatment progress . In case , observation may sufficient . PURPOSE : This clinical trial study well chemotherapy without radiation therapy observation work treat young patient advanced retinoblastoma undergone surgery remove eye .</brief_summary>
	<brief_title>Chemotherapy With Without Radiation Therapy Observation Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery Remove Eye</brief_title>
	<detailed_description>OBJECTIVES : - Compare outcome data child advanced unilateral retinoblastoma historical control order determine whether post-enucleation chemotherapy without radiotherapy improve outcome . - Determine disease-free overall survival child unilateral retinoblastoma adverse histological feature undergo observation enucleation . - Determine toxicity regimens patient . OUTLINE : This nonrandomized study . Patients assign 1 3 treatment group accord histological feature . - Group 1 ( adverse histological feature ) : Patients observe monitored development orbital recurrence metastatic disease . - Group 2a ( deep choroidal invasion and/or retrolaminar invasion optic nerve disease anterior chamber ) : Patients receive carboplatin IV 1 hour , vincristine IV , etoposide IV 4 hour day 1 , , necessary , intrathecal cytarabine day 2 . Treatment repeat every 21 day 4 course . - Group 2b ( invasion cut end optic nerve ) : Patients receive carboplatin IV 1 hour , vincristine IV , etoposide IV 4 hour day 1 , , necessary , intrathecal cytarabine day 2 . Treatment repeat every 21 day 6 course . Patients also undergo orbital radiotherapy 5 day week 4 week . After completion study treatment , patient follow periodically 10 year . PROJECTED ACCRUAL : Not specify</detailed_description>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm unilateral retinoblastoma Prior primary enucleation require No metastatic spread PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior chemotherapy No concurrent steroid antiemetic agent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>intraocular retinoblastoma</keyword>
	<keyword>extraocular retinoblastoma</keyword>
</DOC>